Wellington Management Group’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $349M | Buy |
|
|||||
|
2025
Q2 | $167M | Sell |
|
|||||
|
2025
Q1 | $231M | Sell |
|
|||||
|
2024
Q4 | $355M | Buy |
|
|||||
|
2024
Q3 | $228M | Sell |
|
|||||
|
2024
Q2 | $207M | Buy |
|
|||||
|
2024
Q1 | $139M | Sell |
|
|||||
|
2023
Q4 | $115M | Sell |
|
|||||
|
2023
Q3 | $108M | Buy |
|
|||||
|
2023
Q2 | $64.9M | Sell |
|
|||||
|
2023
Q1 | $58.4M | Buy |
|
|||||
|
2022
Q4 | $51.3M | Buy |
|
|||||
|
2022
Q3 | $51.7M | Buy |
|
|||||
|
2022
Q2 | $34M | Buy |
|
|||||
|
2022
Q1 | $22.6M | Sell |
|
|||||
|
2021
Q4 | $30.4M | Buy |
|
|||||
|
2021
Q3 | $19.2M | Buy |
|
|||||
|
2021
Q2 | $14.1M | Buy |
|
|||||
|
2021
Q1 | $8.44M | Sell |
|
|||||
|
2020
Q4 | $7.85M | Buy |
|
|||||
|
2020
Q3 | $6.86M | Buy |
|
|||||
|
2020
Q2 | $5.45M | Buy |
|